WallStreetZenWallStreetZen

NASDAQ: EVAX
Evaxion Biotech A Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

EVAX earnings and revenue history

Current Revenue
$73.0k
Current Earnings
-$22.1M
Current Profit Margin
-30,308.2%

EVAX Return on Equity

Current Company
-1,238.1%
Current Industry
-63.5%
Current Market
188%
EVAX's Return on Equity (-1,238.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when EVAX announces earnings.

EVAX Return on Assets

Current Company
-126.7%
Current Industry
2.9%
EVAX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

EVAX Return on Capital Employed

Current Company
-365.79%
Current Industry
19.5%
EVAX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EVAX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
EVAX$73.00k-$21.23M-$22.13MN/AN/A
NRBO$0.00-$12.46M-$12.47MN/AN/A
DOMH$2.04M-$22.44M-$22.88M+135.75%N/A
PHGE$0.00-$22.87M-$26.17MN/AN/A
COCP$0.00-$17.16M-$17.98M-100.00%N/A
View Top Biotech Stocks

EVAX earnings dates

Next earnings date
May 29, 2024

Evaxion Biotech A Earnings & Revenue FAQ

What were EVAX's earnings last quarter?

Evaxion Biotech A (NASDAQ: EVAX) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Evaxion Biotech A earnings for the quarter were N/A. In the same quarter last year, Evaxion Biotech A's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Evaxion Biotech A stock.

What was EVAX's earnings growth in the past year?

As of Q2 2024, Evaxion Biotech A's earnings has grown year over year. Evaxion Biotech A's earnings in the past year totalled -$22.13 million.

What is EVAX's earnings date?

Evaxion Biotech A's earnings date is Invalid Date. Add EVAX to your watchlist to be reminded of EVAX's next earnings announcement.

What was EVAX's revenue last quarter?

Evaxion Biotech A (NASDAQ: EVAX) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Evaxion Biotech A's revenue was N/A.

What was EVAX's revenue growth in the past year?

As of Q2 2024, Evaxion Biotech A's revenue has grown null year over year. Evaxion Biotech A's revenue in the past year totalled $73.00 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.